Literature DB >> 20443822

The human heart: a self-renewing organ.

Jan Kajstura1, Toru Hosoda, Claudia Bearzi, Marcello Rota, Silvia Maestroni, Konrad Urbanek, Annarosa Leri, Piero Anversa.   

Abstract

The dogma that the heart is a static organ which contains an irreplaceable population of cardiomyocytes prevailed in the cardiovascular field for the last several decades. However, the recent identification of progenitor cells that give rise to differentiated myocytes has prompted a re-interpretation of cardiac biology. The heart cannot be viewed any longer as a postmitotic organ characterized by a predetermined number of myocytes that is defined at birth and is preserved throughout life. The myocardium constitutes a dynamic entity in which new young parenchymal cells are formed to substitute old damaged dying myocytes. The regenerative ability of the heart was initially documented with a classic morphometric approach and more recently with the demonstration that DNA synthesis, mitosis, and cytokinesis take place in the newly formed myocytes of the normal and pathologic heart. Importantly, replicating myocytes correspond to the differentiated progeny of cardiac stem cells. These findings point to the possibility of novel therapeutic strategies for the diseased heart.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20443822      PMCID: PMC5439577          DOI: 10.1111/j.1752-8062.2008.00030.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  100 in total

1.  Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree?

Authors:  Doris A Taylor; Ralph Hruban; E Rene Rodriguez; Pascal J Goldschmidt-Clermont
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

Review 2.  Modulation of the cardiomyocyte cell cycle in genetically altered animals.

Authors:  Loren J Field
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

Review 3.  Stem cells and repair of the heart.

Authors:  A Mathur; J F Martin
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

Review 4.  Unchain my heart: the scientific foundations of cardiac repair.

Authors:  Stefanie Dimmeler; Andreas M Zeiher; Michael D Schneider
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Biochemical correlates of cardiac hypertrophy. 3. Changes in DNA content; the relative contributions of polyploidy and mitotic activity.

Authors:  D Grove; K G Nair; R Zak
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

6.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

7.  Chimerism of the transplanted heart.

Authors:  Federico Quaini; Konrad Urbanek; Antonio P Beltrami; Nicoletta Finato; Carlo A Beltrami; Bernardo Nadal-Ginard; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

8.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Nikos Werner; Jürgen Haase; Jörg Neuzner; Alfried Germing; Bernd Mark; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2006-11-10       Impact factor: 29.983

9.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs.

Authors:  Y Liu; E Cigola; W Cheng; J Kajstura; G Olivetti; T H Hintze; P Anversa
Journal:  Lab Invest       Date:  1995-12       Impact factor: 5.662

View more
  7 in total

1.  ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.

Authors:  Jelena Zlatkovic-Lindor; D Kent Arrell; Satsuki Yamada; Timothy J Nelson; Andre Terzic
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

Review 2.  K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.

Authors:  D Kent Arrell; Jelena Zlatkovic Lindor; Satsuki Yamada; Andre Terzic
Journal:  Cardiovasc Res       Date:  2011-02-14       Impact factor: 10.787

Review 3.  Cardiac matrix: a clue for future therapy.

Authors:  Paras Kumar Mishra; Srikanth Givvimani; Vishalakshi Chavali; Suresh C Tyagi
Journal:  Biochim Biophys Acta       Date:  2013-09-17

Review 4.  Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation.

Authors:  Zhiqiang Lin; William T Pu
Journal:  Stem Cell Res       Date:  2014-05-06       Impact factor: 2.020

5.  Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype.

Authors:  Satsuki Yamada; Timothy J Nelson; Atta Behfar; Ruben J Crespo-Diaz; Diego Fraidenraich; Andre Terzic
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

6.  Predicting the future with stem cells.

Authors:  Sadia Mohsin; Joseph C Wu; Mark A Sussman
Journal:  Circulation       Date:  2013-11-18       Impact factor: 29.690

Review 7.  Oxytocin and cardioprotection in diabetes and obesity.

Authors:  Marek Jankowski; Tom L Broderick; Jolanta Gutkowska
Journal:  BMC Endocr Disord       Date:  2016-06-07       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.